FDA Panel Recommends Against Approval of Drugs to Treat Hot Flashes

The US Food and Drug Administration has been advised to reject Noven Pharmaceuticals’ drug for treating hot flashes in menopausal women.

An advisory panel to the agency voted 10-4 against approval of the drug with many of the members saying that the benefits of the drug were not enough to outweigh the risks. The panel also voted 12-2 against approving another drug, Depomed's Sefelsa, for similar reasons and added that three clinical trials did not show any marked reduction in hot flashes in menopausal women.

Dealing with Menopause Symptoms Through Lifestyle Changes
You can deal with menopause symptoms such as hot flashes, weight gain and forgetfulness by making simple lifestyle changes.

Depomed’s chief executive, Jim Schoeneck said that his company will stop spending on Sefelsa unless the hurdles for approving similar drugs are not overcome. “Based on today’s meeting we believe the hurdles for approval of a nonhormonal treatment for hot flashes remain high. Until we believe there is a positive direction for Sefelsa, we will cease all spending relating to the product candidate”, he said.

Source-Medindia

Weight Gain After Menopause - Causes - Treatment
Menopause and weight gain in menopause often go hand in hand. But with simple lifestyle changes, menopause weight gain can be easily managed.

About Hot Flash
The frequency of the hot flash can be from 1 to 2 two hot flashes a week to 10 or greater in a day. The silver lining is that it usually decreases over time.